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In a fraction of cytosolic proteins from bovine lung, soluble guanylyl cyclase was concentration-dependently stimulated 
by L-arginine but not by D-arginine. Stimulation was up to 20-fold with an EC,, of about 3 x lo-’ M. Activation of 
guanylyl cyclase by L-arginine was dependent on NADPH (EC,, about 5 x lo1 M) and Ca2+ (EC,, about 1.4 x 10” 
M). The activation by L-arginine was inhibited by W-monomethyl-L-arginine and hemoglobin. The effect of L-arginine 
was dependent on the protein concentration and was not observed in preparations of purified gyanylyl cyclase. These 
results suggest hat bovine lung contains a Ca ‘+-regulated enzyme or enzyme system which converts L-arginine into an 
activator of soluble guanylyl cyclase. 
Arginine; Caz+; Guanylyl cyclase; NADPH 
1. INTRODUCTION 
The endothelium-derived relaxing factor 
(EDRF) that directly activates soluble guanylyl 
cyclase [ 1,2] has been characterized as nitric oxide 
[3]. Biosynthesis of nitric oxide was recently 
described for various mammalian tissues [4-71 
with L-arginine as a precursor [4,8,9]. Marletta et 
al. [lo] have described a cytosolic enzyme in 
macrophages which converts L-arginine into 
citrulline and nitric oxide in the presence of 
NADPH. Palmer et al. [l l] showed that en- 
dothelial cell homogenates convert L-arginine into 
citrulline, but the authors failed to detect a con- 
comitant NO chemiluminescence signal. There is 
no study available until now which directly 
demonstrates enzymatic formation of a bioactive 
moiety from L-arginine. 
In the present paper we describe a 
Ca2+-regulated enzymatic conversion of L-arginine 
into a bioactive metabolite which activates oluble 
guanylyl cyclase and exhibits features similar to 
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EDRF (NO). The enzymatic formation of the 
bioactive metabolite occurred in a fraction of 
cytosolic proteins from bovine lung containing 
soluble guanylyl cyclase, which was used as a 
detection system. 
2. MATERIALS AND METHODS 
2.1. Enzyme preparation 
Bovine lungs (5 kg) were mixed with 1000 ml of a 300 mM 
triethanolamine/HCl buffer, pH 7.0, containing 60 mM ED- 
TA, 6 mM reduced glutathione, 6 mM benzamidine, 60 kE/l 
penicillin G and 60 mg/l streptomycin, and were homogenized 
by means of a Microcut (MC 10, 0.9 mm cutting rings). The 
homogenate was centrifuged for 60 min at 10000 x g.,, and 
phenylmethylsulfonyl f uoride and pepstatin A (final concen- 
trations 0.5 mM and 0.5 ,uM, respectively) were added. The ob- 
tained cytosol was passed over a column of DEAE-Sepharose 
Fast Flow (5 x 13 cm) which had been equilibrated with a 
50 mM triethanolamine/HCl buffer, pH 7.0, containing 
75 mM NaCl, 1 mM EDTA, 2 mM reduced glutathione and 
0.2 mM benzamidine. The column was washed with two bed 
volumes of this buffer; then a linear gradient from 75 to 
400 mM NaCl was applied, and 25-ml fractions were collected. 
Fractions containing guanylyl cyclase activity were pooled, mix- 
ed 1: 1 with glycerol, and &mercaptoethanol(50 mM final con- 
centration) was added to this ‘DEAE fraction’. The protein 
content was 4.0 mg/ml as estimated by the method of Lowry et 
al. modified according to Peterson [12]. The enzyme was stored 
at -80°C for at least two months without loss of enzyme activi- 
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ty. Homogenous guanylyl cyclase was obtained by immunoaf- 
finity chromatography ([13] and manuscript in preparation). 
2.2. Guanylyl cyclase assay 
Formation of 32P-cGMP from [(Y-~*P]GTP was measured as 
previously described [14] in the presence of 0.1 mM 
[~Y-~*P]GTP (specific activity 3-5 TBq/mmol), 1.1 mM MgClz, 
2 mM reduced ghttathione, 1 mM isobutylmethylxanthine, 
1 mM cGMP, 0.5 mg of bovine serum albumin per ml, 50 mM 
triethanolamine/HCl, pH 7.4). Superoxide dismutase, NADPH 
and Ca*+ buffers (see below) were included in the reaction mix- 
ture as indicated. Reactions were carried out in a total volume 
of 0.1 ml at 37°C for 10 min in the presence of 10 ~1 of enzyme 
(40 pg of protein) unless otherwise indicated. 
2.3. Calcium buffers 
L-arginine ( M 1 
Free Ca*+ was adjusted by including in the reaction mixture Fig.]. Effects of L-arginine on guanylyl cyclase activity. An 
1.5 x 10m5 M EGTA, 8.5 x 10m5 M EDTA and CaCl2 as aliquot of the DEAE fraction (40 fig of protein) was incubated 
calculated from the respective stability constants given by for 10 min at 37°C in the presence of 50 U/ml superoxide 
Holloway and Reilley 1151. dismutase, 10-s M Ca*+ and 10m5 M NADPH with increasing 
concentrations of L-arginine. 
2.4. Data evaluation 
Each experiment was performed three times, and each point 
was estimated in triplicate in the absence and presence of L- 
arginine. Guanylyl cyclase activity in the presence of L-arginine 
is given relative to the respective basal activity (fold- 
stimulation; varp/v,), and geometric mean values and SEM were 
calculated. 
Therefore, regulation of enzyme activity via 
substrate availability seems possible but rather 
unlikely. 
2.5. Materials 
Buffer salts of analytical grade were obtained from E. Merck, 
Darmstadt, FRG. [o-‘*P]GTP was prepared from 32PO:- [I61 
obtained from DuPont de Nemours, Dreieich, FRG. DEAE- 
Sepharose Fast Flow was from Pharmacia, Freiburg, FRG, 
NAD, NADP and NADH were from Boehringer Mannheim, 
Mannheim, FRG, hemoglobin from Serva, Heidelberg, FRG, 
and fl-monomethyl-L-arginine[di@-hydroxyazobenzene-p ‘- 
sulfonate] from Calbiochem, Frankfurt, FRG. L- and D- 
arginine, sodium nitroprusside, NADPH, bovine serum 
albumin, manganese-containing superoxide dismutase, cyclic 
GMP, isobutylmethylxanthine, GTP, reduced glutathione, 
phenylmethylsulfonyl fluoride, N-(6-aminohexyl)-5-chloro-l- 
naphthalenesulfonimid (W-7), trifluoperazine, benzamidine 
hydrochloride, penicillin G and streptomycin were obtained 
from Sigma, Deisenhofen, FRG. 
L-Arginine did not activate guanylyl cyclase 
purified by immunoaffinity chromatography from 
the same lung preparation. Deguchi and Yoshioka 
[17] have identified L-arginine as an endogenous 
activator of guanylyl cyclase in neuroblastoma 
cells, but the authors did not test the possibility 
that an enzyme might be involved in guanylyl 
cyclase activation by L-arginine. 
3. RESULTS AND DISCUSSION 
L-Arginine concentration-dependently increased 
guanylyl cyclase activity in the DEAE fraction of 
cytosolic proteins from bovine lung when deter- 
mined in the presence of 10e5 M NADPH and 
10e5 M Ca’+. As shown in fig. 1, L-arginine caused 
an up to 20-fold increase in guanylyl cyclase activi- 
ty, and the estimated EC50 was about 3 x 10e5 M. 
This value is within the range of the intracellular L- 
arginine concentration as determined by Palmer 
and Moncada [l l] in endothelial cell homogenates. 
Further evidence for the assumption that activa- 
tion of soluble guanylyl cyclase requires enzymatic 
conversion of L-arginine was obtained from ex- 
periments in which we compared the effect of 
sodium nitroprusside with the effect of L-arginine 
in the presence of increasing amounts of added 
protein. Fig.2A shows that the effect of sodium 
nitroprusside on guanylyl cyclase activity was in- 
dependent of the protein concentration, whereas 
the effect of L-arginine increased linearly with in- 
creasing protein concentrations, suggesting that an 
activator of soluble guanylyl cyclase was formed 
from L-arginine. 
L-Arginine was utilized stereoselectively by the 
L-arginine-converting enzyme, as D-arginine had 
no effect on soluble guanylyl cyclase activity (not 
shown). N-Benzoyl-L-arginine methylester and L- 
arginine-containing bioactive peptides such as 
bradykinin and tuftsin were only poor substrates. 
Up to a concentration of low4 M, these com- 
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Fig.2. Effects of protein concentration and of incubation time 
on the activation of guanylyl cyclase by L-arginine and sodium 
nitroprusside. (A) Aliquots of the DEAE fraction with protein 
as indicated on the abscissa were diluted with a 50 mM 
triethanolamine/HCl buffer, pH 7.4, containing 0.5 mM 
EDTA, 0.5 mg of bovine serum albumin per ml, and 2 mM 
reduced glutathione; 20 ~1 of diluted enzyme were incubated for 
10 min at 37°C in the presence of 50 U/ml superoxide 
dismutase, 10m5 M Ca*’ and 10e5 M NADPH in the presence 
or absence of low4 M L-arginine (filled symbols) or lo-’ M 
sodium nitroprusside (unfilled symbols) in a total volume of 
0.1 ml. Guanylyl cyclase activity in the presence of activator is 
given relative to the basal activity (V./I@. (B) An aliquot of the 
DEAE fraction (4Ocg of protein) was preincubated for 2 min 
at 37°C with the reaction mixture described in section 2, 
containing lo-’ M NADPH and 10m5 M Ca*+ in the presence 
(solid line) and absence (dashed line) of 50 U/ml superoxide 
dismutase. Incubations were carried out for the indicated 
periods of time at 37°C without and with 10e4 M L-arginine. 
pounds caused between 10 and 20% guanylyl 
cyclase stimulation when compared to L-arginine, 
which finding confirms the suggestion of Palmer et 
al. [l l] that peptidyl-arginine deiminase may not 
be involved in the biosynthesis of EDRF. 
fl-Monomethyl-arginine (10e4 M), an inhibitor 
of nitric oxide biosynthesis and endothelium- 
dependent relaxation [ 11,18,19], and hemoglobin 
(10m6 M), an inhibitor of activation of guanylyl 
cyclase by NO-containing compounds and of 
endothelium-dependent relaxation [20], markedly 
decreased the effect of L-arginine to about 14% 
and 8070, respectively (not shown). 
Superoxide dismutase has been described to 
stabilize nitric oxide [3]. Fig.2B shows the results 
obtained when DEAE fraction was incubated for 
increasing periods of time with L-arginine in the 
absence and presence of superoxide dismutase. 
The degree of guanylyl cyclase activation was con- 
siderably decreased as compared to other ex- 
periments described, probably due to an 
inactivation of the L-arginine-converting enzyme 
or an essential cofactor in the course of the re- 
quired preincubation without added L-arginine 
and GTP (2 min, 37°C). A rapid increase in 
guanylyl cyclase activation occurred within the 
first 60 s of incubation time. Subsequently, the ef- 
fect of L-arginine remained constant over a period 
of 15 min in the presence of superoxide dismutase, 
whereas it decreased continuously in the absence of 
superoxide dismutase. The observed enhancement 
of the effect of L-arginine by superoxide dismutase 
and the development of a steady state are consis- 
tent with the formation of a labile metabolite from 
L-arginine which is stabilized by superoxide 
dismutase. 
The results obtained with fl-monomethyl- 
arginine, hemoglobin and superoxide dismutase 
suggest that an activator of soluble guanylyl 
cyclase is formed which has features comparable 
with EDRF, and we, therefore, conclude that ac- 
tivation of guanylyl cyclase by L-arginine reflects 
biosynthesis of nitric oxide or a closely related 
compound. 
Fig.3A shows that the guanylyl cyclase- 
stimulating activity of L-arginine was dependent 
on NADPH; this finding confirms results obtained 
previously on nitric oxide biosynthesis in 
macrophages [lo]. The ECso for NADPH was very 
low (about 5 x lo-’ M), and the enzyme appears 
to selectively depend on this nucleotide, since only 
about 16% of the effect were observed in the 
presence of lo-’ M NADP+. NAD+ as well as 
NADH (each up. to lo-’ M) completely failed to 
act as cofactors for the L-arginine-converting 
enzyme. 
The release of EDRF from endothelial cells was 
shown to be associated with increases of in- 
tracellular free Ca2+ [21]. Fig.3B shows the 
concentration-response curve which was obtained 
when the DEAE fraction was incubated in the 
presence and absence of 10M4 M L-arginine with 
increasing concentrations of free Ca2+. Up to 
10m4 M, Ca2+ did not alter basal guanylyl cyclase 
activity. No effect of L-arginine was observed 
when EDTA (1.35 x 10e4 M) and EGTA (1.5 x 
lo-’ M) were present in the incubation mixture 
without exogenously added Ca2+. The 
concentration-response curve showed a maximum 
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Fig.3. Effects of NADPH and of Ca” on the activation of 
guanylyl cyclase by L-arginine. (A) An aliquot of the DEAE 
fraction (20 $8 of protein) was incubated for 10 min at 37°C in 
the presence of 10m5 M Ca*” and 50 U/ml superoxide 
dismutase with increasing concentrations of NADPH. Stock 
solutions of NADPH were freshly prepared in 50 mM 
triethanoiamine/HCl, pH 7.5. Guanylyl cyclase activity was 
estimated in the absence and presence of 10m4 M L-arginine. (B) 
An aiiquot of the DEAE fraction (4O~g of protein) was 
incubated in the presence of IO-’ M NADPH and SO U/ml 
superoxide dismutase for 10 min at 37°C with increasing 
concentrations of free Ca*+ (for adjusting the free Ca*+ 
concentrations ee section 2). Guanylyl cyclase activity was 
estimated in the absence and presence of 10m4 M L-arginine. 
of guanylyl cyclase activation at lOA M free Ca2+ 
with an EC& of about 1.4 x 10m6 M. The L- 
arginine-converting enzyme, therefore, appears to 
be regulated directly or indirectly by physiological- 
ly occurring concentrations of free Ca2+, which, 
therefore, may mediate hormone-induced EDRF 
release. The calmodulin antagonists, N- 
(6-aminohexyl)-5-chloro-l-naphthalenesulfonami- 
de (W-7) and trifluoperazine [22], at concentra- 
tions up to 10T5 M did not alter activation of 
guanylyl cyclase by L-arginine, suggesting that the 
effect of Ca2+ was not mediated via calmodulin. 
Summarizing the data presented in this paper, 
we conclude that in bovine lung, which is rich in 
vascular tissue, exists an enzyme which 
Ca’+-dependently converts L-arginine into an ac- 
tivator of soluble guanylyl cyclase. This labile L- 
arginine metabolite appears to be identical with 
EDRF and may represent nitric oxide or a closely 
related compound. The bioassay applied in this 
study represents a powerful tool for the investiga- 
tion of EDRF biosynthesis, especially in the 
purification of the enzyme involved. 
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